A Clinical Trial to Evaluate the Relative Bioavailability of New and Old ABSK-011 Capsules

Clinical trial NCT06306872 · COMPLETED

Trial details

NCT number: NCT06306872
Sponsor: Abbisko Therapeutics Co, Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2024-02-23
Primary completion: 2025-09-30
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.